Abingworth is an international bioscience investment firm that invests in seed stage projects, technology platforms, preclinical and clinical assets, and approved and marketed products. Its venture funds are focused on strategic areas of venture capital, clinical co-development, venture investments in public equities (VIPEs), and public markets. The firm supports companies at all stages of development, from start-ups to publicly traded companies, across all life sciences sectors, including biotherapeutics, small molecules, nucleic acid therapeutics, vaccines, specialty pharma, technologies, medical devices, diagnostics, and instrumentation.
Abingworth has 1.02k Twitter Followers. The number of followers has increased 3.3% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Abingworth founded?
Abingworth was founded in 1973.
Who are Abingworth key executives?
Abingworth's key executives are Tim Haines, Kurt von Emster and Genghis Lloyd-Harris.
How many employees does Abingworth have?
Abingworth has 27 employees.
What is Abingworth revenue?
Latest Abingworth annual revenue is £14.7 m.
What is Abingworth revenue per employee?
Latest Abingworth revenue per employee is £543.9 k.
Who are Abingworth competitors?
Competitors of Abingworth include Synergy55, ZX Ventures and Allianz X.
Where is Abingworth headquarters?
Abingworth headquarters is located at 33 Jermyn St, St. James's, London.
Where are Abingworth offices?
Abingworth has offices in London, Boston and Menlo Park.
How many offices does Abingworth have?
Abingworth has 3 offices.
Receive alerts for 300+ data fields across thousands of companies